Trial intelligence / Profile preview

Tacrolimus for prevention of erectile dysfunction after prostatectomy

NCT00106392Phase 4Completed

Sponsor
Astellas Pharma
Start
Feb 2005
Primary completion
Apr 2008
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in erectile dysfunction (ED) comparing Tacrolimus with Placebo (2 arms). Primary endpoint: Erectile Function Domain Score at 18 months. Started Feb 2005; status: completed.

02

Drugs

tacrolimus + Wuzhi capsule
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on NCT00106392.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00106392.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call